Clinical study using samples of patients experienced side effects by influenza vaccine
Not Applicable
- Conditions
- systemic side effect of vaccines
- Registration Number
- JPRN-UMIN000013064
- Lead Sponsor
- ational Institutes of Biomedical Innovation,Health and Nutrition
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
Not provided
Exclusion Criteria
Not obtained the consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study measure serum micro RNA, antibody and cytokines of patients experienced side effects such as anaphylaxis. And also measure serum micro RNA of person who has diathesis of allergic diseases or healthy people.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie systemic side effects from influenza vaccines in clinical populations?
Are there specific biomarkers that identify patients at higher risk for systemic vaccine adverse events?
How do the observed side effects in this trial compare to standard-of-care vaccine safety profiles?
What alternative vaccine formulations or adjuvants could mitigate systemic adverse reactions?
What immune response pathways are associated with systemic vaccine side effects in this cohort?